Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
NORDBIOTIC Plastic FreeGut is a probiotic dietary supplement in preclinical development by Nordic Biotic, specifically designed to mitigate the health impacts of microplastic exposure in the gastrointestinal tract. The formulation consists of proprietary bacterial strains selected for their functional ability to bind and sequester microplastic particles within the gut environment. By facilitating the removal of these particles or reducing their interaction with the intestinal epithelium, the product aims to prevent microplastic-induced inflammation and maintain gut barrier integrity. Current development involves in vitro and functional studies to validate the selective removal and sequestration capabilities of the microbial strains.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on NORDBIOTIC Plastic FreeGut.